bluebird bio (NASDAQ:BLUE) – Piper Jaffray Companies issued their Q2 2018 earnings estimates for bluebird bio in a research note issued on Wednesday, May 30th. Piper Jaffray Companies analyst T. Van. Buren anticipates that the biotechnology company will post earnings per share of ($2.90) for the quarter. Piper Jaffray Companies has a “Buy” rating and […]
